Lenalidomide Exposure and TP53-Mutated Myelodysplastic Syndromes/Neoplasms

Related

• Germline HRD limits therapy-driven clonal hematopoiesis

  Nature Genetics · 4 Oct 2026

• Donor TET2 variant linked to lower stem cell transplant survival

  International Journal of Molecular Sciences · 4 Oct 2026